Core Viewpoint - The company reported a revenue of RMB 653 million for the six months ending June 30, 2025, representing a year-on-year increase of 1.7% and a net profit of RMB 35.9 million, which is a 33.5% increase compared to the same period in 2024 [1] Revenue Breakdown - The revenue primarily came from two sources: (i) sales of ophthalmic medical devices and consumables, and (ii) provision of technical services [1] Market Performance - The company's ability to maintain revenue growth in a persistently weak global economic environment is attributed to the expansion in overseas markets and the synergistic effect of increased revenue from proprietary products [1]